Shengyang He
Impact in
-
- Antibiotic Use and Resistance
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Neonatal Respiratory Health Research 4
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- Autophagy in Disease and Therapy 3
- Co-authors
- Lihua Xie (10 shared papers)Shenghua Sun (7 shared papers)Peng Huang (1 shared paper)Mengyun Hu (2 shared papers)Mingyan Jiang (1 shared paper)Zhi Xiang (1 shared paper)Wenlong Liu (1 shared paper)Ping Chen (1 shared paper)
In The Last Decade
Shengyang He
11 papers receiving 291 citations
Peers
Comparison fields: 5 of 69
- Applied Microbiology and Biotechnology 31
- Cancer Research 62
- Pulmonary and Respiratory Medicine 110
- Critical Care and Intensive Care Medicine 16
- Infectious Diseases 52
Countries citing papers authored by Shengyang He
This map shows the geographic impact of Shengyang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyang He more than expected).
Fields of papers citing papers by Shengyang He
This network shows the impact of papers produced by Shengyang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyang He. The network helps show where Shengyang He may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengyang He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 66 | |
| 2 | 2019 | 58 | |
| 3 | 2021 | 53 | |
| 4 | 2018 | 35 | |
| 5 | 2018 | 28 | |
| 6 | 2020 | 15 | |
| 7 | 2021 | 14 | |
| 8 | 2020 | 13 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 3 | |
| 11 | 2022 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2011 | 0 | |
| 16 | 2022 | 0 |
About Shengyang He
Shengyang He is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology, Infectious Diseases and Surgery, having authored 16 papers that have together received 291 indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Autophagy in Disease and Therapy (3 papers), COVID-19 diagnosis using AI (2 papers), MicroRNA in disease regulation (2 papers), COVID-19 Clinical Research Studies (2 papers), Congenital Diaphragmatic Hernia Studies (2 papers) and Hydrogen's biological and therapeutic effects (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (31 citations), Cancer Research (62 citations), Pulmonary and Respiratory Medicine (110 citations), Critical Care and Intensive Care Medicine (16 citations) and Infectious Diseases (52 citations). Shengyang He has collaborated with scholars based in China and Australia. Frequent co-authors include Lihua Xie, Shenghua Sun, Peng Huang, Mengyun Hu, Mingyan Jiang, Zhi Xiang, Wenlong Liu, Ping Chen, Dingding Deng and Caihong Liu. Their work appears in journals such as Scientific Reports, Tobacco Induced Diseases, Respiratory Research, PLoS ONE and Growth Factors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.